Single window clearance for GM drugs
Biotech companies will now be able to get a single window clearance for the manufacture and sale or genetically modified therapeutic products (recombinant drugs). A committee of experts will be set
Biotech companies will now be able to get a single window clearance for the manufacture and sale or genetically modified therapeutic products (recombinant drugs). A committee of experts will be set